Description:

Study ID: 111406 Clinical Study ID: 111406 Study Title: A First-Time-in-Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1399686 After Single and Repeated Oral Dosing in Healthy Volunteers using a Dose- Escalating, Randomized, Placebo-Controlled Study Design Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00721812 Sponsor: GlaxoSmithKline Phase: Phase 1 Study Recruitment Status: Completed Generic Name: Placebo, locally-acting anti-inflammatory compound GSK1399686 Study Indication: Inflammatory Bowel Diseases

Keywords:
Versions (1) ▾
  1. 5/18/21
Copyright Holder:
GlaxoSmithKline
Uploaded on:

May 18, 2021

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY 4.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Safety, Tolerability and Pharmacokinetics of GSK1399686 After Single and Repeated Oral Dosing NCT00721812

Pregnancy Notification Form (Subject's Partner)

Administrative
Pregnancy Notification Form (Subject's Partner) - Mother's Relevant Medical/Family History
Was the mother using a method of contraception?
Type of conception
Are there any additional factors that may have an impact on the outcome of this pregnancy?
Pregnancy Notification Form (Subject's Partner) - Father's Relevant Medical/Family History
Pregnancy Notification Form (Subject's Partner) - Drug Exposures
Medication Started Pre-Study
Ongoing Medication
Was the subject withdrawn from the study as a result of this pregnancy?
Was the subject withdrawn from the study as a result of this pregnancy?
Pregnancy Notification Form (Subject's Partner) - Reporting Investigator Information

Similar models